Viewing Study NCT07262268

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-01-04 @ 4:16 PM
Study NCT ID: NCT07262268
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
Sponsor: Biohaven Therapeutics Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Familial Erythromelalgia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Erythomelalgia View
None IEM View
None Primary Erythomelalgia View
None SCN9A View
None NaV1.7 View
None Channelopathy View
None Red Neuralgia View
None Neuropathic Pain View
None Inherited Erythomelalgia View